TP53 and lymphoma: However, the reduction of readily detectable defects in TRP53 pathway function in the lymphomas from the p21−/−Zmat3−/− mice indicates that the absence of these two TRP53 target genes may obviate the selection for mutations in Trp53 in this malignant disease.